![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](hg2004contents.gif)
Acta Cryst. (2006). E62, o1019-o1021 [ doi:10.1107/S1600536806004727 ]
-(5-methyl-1,3,4-oxadiazol-2-yl)-13,16-seco-17-norandrost-4-en-3-oneAbstract: In the title compound, a seco steroid derivative, C21H27N3O2, the cyclohexane rings of the steroid nucleus are in chair conformations, while the cyclohexene ring adopts a 1
-sofa conformation. In the crystal structure, intermolecular C-H
N interactions link the molecules into extended chains, parallel to the c axis, with graph-set motif C(5). The structure is further stabilized by weak intermolecular C-H
O interactions which can be described as C(4) chains running parallel to the b axis.
Online 15 February 2006
Copyright © International Union of Crystallography
IUCr Webmaster